Moderna jumps on vaccine cancer breakthrough; stock tops 491% for year
Moderna (MRNA) stock is now up 491% for the year after surging 177% on Wednesday following its vaccine cancer breakthrough, according to the raw item.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.